IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — FRSX

Balance Sheet

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Cash & Equivalents6.3411.9717.0325.0223.75
Short-term Investments0.030.020.0010.5128.46
Accounts Receivable0.030.21------
Total Current Assets6.8812.8018.3636.2152.88
Property, Plant & Equipment0.210.380.570.650.41
Total Non-current Assets1.672.623.895.276.34
Total Assets8.5515.4122.2541.4859.22
Total Current Liabilities1.712.212.002.412.33
Total Non-current Liabilities*1.211.691.371.631.55
Total Liabilities2.923.903.374.043.87
Retained Earnings(137.05)(124.60)(112.13)(91.94)(72.29)
Total Stockholder Equity5.9310.8818.3237.0955.20

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Total Revenue0.130.120.210.21--
Cost of Revenue0.040.040.020.09--
Gross Profit0.090.090.030.12--
Research & Development2.162.373.152.812.44
Selling, General & Admin0.590.610.720.840.81
Total Operating Expenses3.043.299.034.25--
Operating Income(2.95)(3.20)(4.35)(4.12)(3.74)
Interest Expense----0.000.00--
Net Income(2.76)(3.17)(6.06)(10.12)(3.16)
Basic EPS(0.01)--(0.02)----
Diluted EPS(0.01)--(0.02)----

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow(2.61)(2.54)(3.51)(3.28)(3.97)
Capital Expenditures0.000.020.020.070.04
Free Cash Flow*(2.61)(2.56)(3.53)(3.35)(4.01)
Investing Cash Flow-0.00(0.02)(0.02)2.29(3.38)
Financing Cash Flow(0.09)(0.09)----13.08

* Derived from reported values